Developer docs
API playgroundTry for free, no card

Search company profiles

YPrime

Full company profile

uuid0004ho6

Namestring
YPrime
Legal namestring
Y-Prime, LLC
Websiteurl
yprime.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

YPrime is a privately held clinical trial technology company founded in 2006 and headquartered in Malvern, Pennsylvania, operating as Y-Prime, LLC with a wholly-owned UK subsidiary (Y-Prime UK Ltd.). The company provides an integrated eClinical platform built around three core products — eCOA (Electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), and eConsent — supplemented by participant engagement tools, consulting services, and 24/7/365 in-house expert support. YPrime reports approximately 1,000 studies implemented globally across more than 100 countries and 19 therapeutic areas, with more than 125,000 patients engaged on its platform and customers including top-15 pharmaceutical sponsors, emerging biotechs, CROs, and clinical research sites.

The platform is built on a fully configurable, no-code architecture accessible across devices and integrates eCOA, IRT, and eConsent workflows to support complex global protocols. Differentiated technical components include a proprietary AI Migration Tool that automates eCOA localization (74% reduction in migration errors, 67% faster review cycles), an AI Calculation Engine that uses natural language input to configure clinical trial data calculations, a Participant Hub with a 'For You' engagement page, Advanced eCOA Oversight with attributable electronic signatures aligned to EMA, FDA, and ICH guidelines, and a Data Suite providing near real-time reporting with inspection-ready audit trails. The platform is sold via direct enterprise field sales, RFP- and demo-driven engagement, and ecosystem integrations such as the Advarra Study Collaboration partnership, which provides single sign-on access to more than 225,000 study team members.

YPrime's revenue model combines subscription-based platform licensing (eCOA, IRT, eConsent) with professional consulting services and bundled global support, priced via quote-based enterprise contracts tailored to study complexity, scope, and duration. The company is structured as a privately held LLC with no disclosed funding rounds, no parent company, and no public listing, suggesting it is founder- or management-owned and operating cash-flow positive. Recent strategic activity has centered on AI-enabled product launches, a major platform refresh, and ecosystem partnerships that broaden distribution without reliance on external capital.

Short descriptiontext

YPrime provides configurable eCOA, IRT, and eConsent software platforms for global clinical trials, serving pharmaceutical sponsors, biotechs, and CROs across 100+ countries through proprietary AI-powered localization, 24/7 expert support, and integrated participant engagement tools.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersMalvern, United States
HQ citystring
Malvern
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electronic clinical outcome assessment, interactive response technology, electronic informed consent, clinical trial eClinical platform, clinical trial technology solutions
Industry2 codes
PRIMARYHLACAOAC
Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code1 code
  • Computer Systems Design Services541512
SIC code1 code
  • Services-Prepackaged Software7372
Product category
eClinical Technology / Clinical Trial Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1eClinical Technology Platform (eCOA, IRT, eConsent)
TypeSubscription Recurring
Description

SaaS/platform licensing model for clinical trial technology. The company provides configurable software platforms for electronic data capture in clinical trials, with implementation, configuration, and ongoing platform access as core revenue components.

yprime.com
2Consulting Services
TypeProfessional Services
Description

Expert guidance services extending the clinical trial technology platform, including process optimization, technology alignment with protocol and regulatory requirements, system integration, and data workflow consulting.

yprime.com
324/7/365 Global Support
TypeSubscription Recurring
Description

In-house support desk staffed by eClinical experts providing round-the-clock assistance to sponsors, CROs, and clinical research sites, bundled with platform services.

yprime.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

YPrime provides a unified eClinical technology platform for global clinical trials, delivering enterprise-grade eCOA (Electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), and eConsent solutions, complemented by participant engagement tools and clinical trial consulting services. The platform is designed to accelerate study startup, support complex protocols, and provide inspection-ready data across 100+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 74% reduction in eCOA migration errors with AI-enabled workflows across 15 studies in 11 languages
+6 more records
Product overview1 text field

YPrime offers a unified Clinical Trial Technology Platform comprising four core products: eCOA (Electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), eConsent, and Participant Engagement. The platform is built with configurable architecture and integrated data flows for global clinical trial execution. Core modules include eCOA for patient-reported data capture, IRT for randomization and supply management, and eConsent for enrollment. Additional offerings include the Participant Hub (an in-app engagement tool), Advanced eCOA Oversight (for investigator accountability), Data Suite (for near real-time reporting), and AI-powered tools including the AI Calculation Engine and AI Migration Tool. The company also provides consulting services to extend the platform's capabilities.

Product and service8 records
1Clinical Trial Technology Platform
CategoryeClinical Platform
Description

Unified eClinical technology platform integrating eCOA, IRT, and eConsent solutions with configurable architecture, integrated data flows, and consistent global delivery across 100+ countries, sold to pharmaceutical sponsors, biotechs, and CROs.

2eCOA (Electronic Clinical Outcome Assessment)
CategoryElectronic Clinical Outcome Assessment
Description

Enterprise-grade electronic clinical outcome assessment platform for capturing patient-reported, clinician-reported, observer-reported, and performance outcomes with 100% configurable, no-code design accessible across devices. Accelerates study startup timelines by approximately 50%.

3IRT (Interactive Response Technology)
CategoryInteractive Response Technology
Description

Industry-leading interactive response technology platform supporting complex trial designs, rapid protocol updates, randomization, and drug supply management without operational bottlenecks. Used in global vaccine, cardiovascular, and large-scale pharmaceutical trials.

4eConsent
CategoryElectronic Informed Consent
Description

Intuitive electronic informed consent platform that streamlines clinical trial enrollment, improves patient understanding of study requirements, and reduces site burden through user-friendly design and regulatory compliance.

5Participant Engagement
CategoryPatient Engagement
Description

Patient engagement solutions embedded within eCOA and eConsent workflows, leveraging user-friendly design, personalization, and behavioral science to drive clinical trial participant retention and adherence.

6Consulting Services
CategoryProfessional Services
Description

Clinical trial consulting services that extend the technology platform with expert guidance on process optimization, technology alignment with protocol and regulatory requirements, system integration, and data workflow management.

7Participant Hub
CategoryParticipant Engagement Software
Description

In-app participant experience within the eCOA platform featuring a 'For You' page that centralizes study information, visit schedules, task tracking, and embedded protocol guidance to improve clinical trial adherence and reduce dropout rates.

8AI Migration Tool
CategoryAI Localization Software
Description

Proprietary AI-powered tool for eCOA localization that automates migration of translated assessments into eCOA software, reducing errors by 74% and accelerating localization review cycles by 67% across 15 studies in 11 languages.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-10
Description

YPrime is integrated as one of five eClinical technology partners in Advarra's Study Collaboration solution, providing single sign-on (SSO) access for sponsors, CROs, and research sites to access YPrime eCOA alongside EDC, eConsent, IRT/RTSM, payments, and patient engagement tools. More than 225,000 study team members use the platform, with the expansion designed to reduce administrative burden, improve adoption, and strengthen security through centralized access controls.

Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

CSC partnered with YPrime to execute a focused, risk-based UAT strategy for IRT implementations, providing dedicated UAT support and execution expertise to help streamline coordination, testing workflows, and issue resolution during validation. The partnership enabled accelerated validation while preserving rigor and oversight required for complex IRT and eCOA implementations.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Cloud-based eClinical platform with EDC, eCOA, and eConsent offerings positioned as a modern, configurable alternative — partial overlap with YPrime's eCOA and eConsent products at smaller and emerging biotech customers.

TypeBroad incumbent
Description

Largest CRO with proprietary eClinical technology stack including EDC, RTSM, and eCOA; competes with YPrime both as a buyer of third-party platforms and as a vendor offering integrated clinical technology solutions.

TypeDirect peer
Description

Specialist eCOA, eConsent, and patient engagement vendor (formed from CRF Health + Bracket) with comparable focus on configurable clinical outcome assessments and global trial deployment.

TypeBroad incumbent
Description

Large life-sciences cloud platform whose Vault CDB and Vault eCOA offerings compete head-to-head with YPrime's IRT and eCOA as part of a broader clinical, regulatory, and commercial suite.

TypeEmerging player
Description

Patient-centric DCT platform offering eConsent, eCOA, remote patient engagement, and connected device integrations — overlapping with YPrime's Participant Hub and eConsent capabilities in decentralized trial use cases.

TypeDirect peer
Description

Direct eCOA and decentralized clinical trial technology competitor formed from ERT and Bioclinica, offering electronic outcome assessments, imaging, and respiratory services to global pharma sponsors.

TypeDirect peer
Description

Specialist IRT/RTSM and eCOA vendor for complex clinical trials — directly comparable to YPrime's IRT product and competes for similar oncology and rare disease trial mandates.

8Oracle Health Sciences (Clinical One / InForm)
TypeBroad incumbent
Description

Broad incumbent offering EDC (InForm), RTSM, eCOA, and safety in an integrated platform; competes with YPrime on enterprise sponsor RFPs with significantly greater scale and integration depth.

TypeDirect peer
Description

Industry-leading eClinical platform offering Rave EDC, Rave eCOA, and RTSM/IRT — directly competes with YPrime's eCOA and IRT products for global pharmaceutical sponsor business at much larger scale.

TypeDirect peer
Description

Clinical trial workflow technology provider with eCOA, CTMS, and scheduling solutions; competes with YPrime particularly in mid-sized sponsor and academic trial segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

YPrime

eClinical Technology / Clinical Trial Softwareyprime.com

YPrime provides configurable eCOA, IRT, and eConsent software platforms for global clinical trials, serving pharmaceutical sponsors, biotechs, and CROs across 100+ countries through proprietary AI-powered localization, 24/7 expert support, and integrated participant engagement tools.

What YPrime does

YPrime is a privately held clinical trial technology company founded in 2006 and headquartered in Malvern, Pennsylvania, operating as Y-Prime, LLC with a wholly-owned UK subsidiary (Y-Prime UK Ltd.). The company provides an integrated eClinical platform built around three core products — eCOA (Electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), and eConsent — supplemented by participant engagement tools, consulting services, and 24/7/365 in-house expert support. YPrime reports approximately 1,000 studies implemented globally across more than 100 countries and 19 therapeutic areas, with more than 125,000 patients engaged on its platform and customers including top-15 pharmaceutical sponsors, emerging biotechs, CROs, and clinical research sites.

The platform is built on a fully configurable, no-code architecture accessible across devices and integrates eCOA, IRT, and eConsent workflows to support complex global protocols. Differentiated technical components include a proprietary AI Migration Tool that automates eCOA localization (74% reduction in migration errors, 67% faster review cycles), an AI Calculation Engine that uses natural language input to configure clinical trial data calculations, a Participant Hub with a 'For You' engagement page, Advanced eCOA Oversight with attributable electronic signatures aligned to EMA, FDA, and ICH guidelines, and a Data Suite providing near real-time reporting with inspection-ready audit trails. The platform is sold via direct enterprise field sales, RFP- and demo-driven engagement, and ecosystem integrations such as the Advarra Study Collaboration partnership, which provides single sign-on access to more than 225,000 study team members.

YPrime's revenue model combines subscription-based platform licensing (eCOA, IRT, eConsent) with professional consulting services and bundled global support, priced via quote-based enterprise contracts tailored to study complexity, scope, and duration. The company is structured as a privately held LLC with no disclosed funding rounds, no parent company, and no public listing, suggesting it is founder- or management-owned and operating cash-flow positive. Recent strategic activity has centered on AI-enabled product launches, a major platform refresh, and ecosystem partnerships that broaden distribution without reliance on external capital.

YPrime firmographics

Firmographics
Name
YPrime
Legal name
Y-Prime, LLC
Website
https://yprime.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
251–500 employees
Short description
YPrime provides configurable eCOA, IRT, and eConsent software platforms for global clinical trials, serving pharmaceutical sponsors, biotechs, and CROs across 100+ countries through proprietary AI-powered localization, 24/7 expert support, and integrated participant engagement tools.
Ownership category
akta.pro rank

YPrime industry classification

Industry
Product category
eClinical Technology / Clinical Trial Software
NAICS
Computer Systems Design Services (541512)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAOAC
Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Electronic clinical outcome assessment
  • Interactive response technology
  • Electronic informed consent
  • Clinical trial eClinical platform
  • Clinical trial technology solutions

Where YPrime is headquartered

Location

Headquarters

HQ city
Malvern
HQ country
United States
HQ region
North America

Offices5 records

Markets served

YPrime business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. eClinical Technology Platform (eCOA, IRT, eConsent): SaaS/platform licensing model for clinical trial technology. The company provides configurable software platforms for electronic data capture in clinical trials, with implementation, configuration, and ongoing platform access as core revenue components.
  2. Consulting Services: Expert guidance services extending the clinical trial technology platform, including process optimization, technology alignment with protocol and regulatory requirements, system integration, and data workflow consulting.
  3. 24/7/365 Global Support: In-house support desk staffed by eClinical experts providing round-the-clock assistance to sponsors, CROs, and clinical research sites, bundled with platform services.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

YPrime product offering

Product offering

Core offering

YPrime provides a unified eClinical technology platform for global clinical trials, delivering enterprise-grade eCOA (Electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), and eConsent solutions, complemented by participant engagement tools and clinical trial consulting services. The platform is designed to accelerate study startup, support complex protocols, and provide inspection-ready data across 100+ countries.

Product overview

YPrime offers a unified Clinical Trial Technology Platform comprising four core products: eCOA (Electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), eConsent, and Participant Engagement. The platform is built with configurable architecture and integrated data flows for global clinical trial execution. Core modules include eCOA for patient-reported data capture, IRT for randomization and supply management, and eConsent for enrollment. Additional offerings include the Participant Hub (an in-app engagement tool), Advanced eCOA Oversight (for investigator accountability), Data Suite (for near real-time reporting), and AI-powered tools including the AI Calculation Engine and AI Migration Tool. The company also provides consulting services to extend the platform's capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Trial Technology Platform Unified eClinical technology platform integrating eCOA, IRT, and eConsent solutions with configurable architecture, integrated data flows, and consistent global delivery across 100+ countries, sold to pharmaceutical sponsors, biotechs, and CROs.
  • eCOA (Electronic Clinical Outcome Assessment) Enterprise-grade electronic clinical outcome assessment platform for capturing patient-reported, clinician-reported, observer-reported, and performance outcomes with 100% configurable, no-code design accessible across devices. Accelerates study startup timelines by approximately 50%.
  • IRT (Interactive Response Technology) Industry-leading interactive response technology platform supporting complex trial designs, rapid protocol updates, randomization, and drug supply management without operational bottlenecks. Used in global vaccine, cardiovascular, and large-scale pharmaceutical trials.
  • eConsent Intuitive electronic informed consent platform that streamlines clinical trial enrollment, improves patient understanding of study requirements, and reduces site burden through user-friendly design and regulatory compliance.
  • Participant Engagement Patient engagement solutions embedded within eCOA and eConsent workflows, leveraging user-friendly design, personalization, and behavioral science to drive clinical trial participant retention and adherence.
  • Consulting Services Clinical trial consulting services that extend the technology platform with expert guidance on process optimization, technology alignment with protocol and regulatory requirements, system integration, and data workflow management.
  • Participant Hub In-app participant experience within the eCOA platform featuring a 'For You' page that centralizes study information, visit schedules, task tracking, and embedded protocol guidance to improve clinical trial adherence and reduce dropout rates.
  • AI Migration Tool Proprietary AI-powered tool for eCOA localization that automates migration of translated assessments into eCOA software, reducing errors by 74% and accelerating localization review cycles by 67% across 15 studies in 11 languages.

Quantifiable outcome

  • 74% reduction in eCOA migration errors with AI-enabled workflows across 15 studies in 11 languages
  • +6 more outcomes

Companies that use YPrime

Customer profile

Named customers10 records

Segments8 records

Ideal customer profiles3 records

YPrime technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

YPrime partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and supporting.

  • AdvarracoreTechnology or Integration · 10 December 2025YPrime is integrated as one of five eClinical technology partners in Advarra's Study Collaboration solution, providing single sign-on (SSO) access for sponsors, CROs, and research sites to access YPrime eCOA alongside EDC, eConsent, IRT/RTSM, payments, and patient engagement tools. More than 225,000 study team members use the platform, with the expansion designed to reduce administrative burden, improve adoption, and strengthen security through centralized access controls.
  • Clinical Supply Consulting (CSC)supportingImplementation/ SI/ Consulting PartnerCSC partnered with YPrime to execute a focused, risk-based UAT strategy for IRT implementations, providing dedicated UAT support and execution expertise to help streamline coordination, testing workflows, and issue resolution during validation. The partnership enabled accelerated validation while preserving rigor and oversight required for complex IRT and eCOA implementations.

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

YPrime competitors and assessment

Company assessment

Emerging players

  • Castor: Cloud-based eClinical platform with EDC, eCOA, and eConsent offerings positioned as a modern, configurable alternative — partial overlap with YPrime's eCOA and eConsent products at smaller and emerging biotech customers.
  • ClinOne: Patient-centric DCT platform offering eConsent, eCOA, remote patient engagement, and connected device integrations — overlapping with YPrime's Participant Hub and eConsent capabilities in decentralized trial use cases.

Broad incumbents

  • IQVIA: Largest CRO with proprietary eClinical technology stack including EDC, RTSM, and eCOA; competes with YPrime both as a buyer of third-party platforms and as a vendor offering integrated clinical technology solutions.
  • Veeva Systems: Large life-sciences cloud platform whose Vault CDB and Vault eCOA offerings compete head-to-head with YPrime's IRT and eCOA as part of a broader clinical, regulatory, and commercial suite.
  • Oracle Health Sciences (Clinical One / InForm): Broad incumbent offering EDC (InForm), RTSM, eCOA, and safety in an integrated platform; competes with YPrime on enterprise sponsor RFPs with significantly greater scale and integration depth.

Direct peers

  • Signant Health: Specialist eCOA, eConsent, and patient engagement vendor (formed from CRF Health + Bracket) with comparable focus on configurable clinical outcome assessments and global trial deployment.
  • Clario: Direct eCOA and decentralized clinical trial technology competitor formed from ERT and Bioclinica, offering electronic outcome assessments, imaging, and respiratory services to global pharma sponsors.
  • Suvoda: Specialist IRT/RTSM and eCOA vendor for complex clinical trials — directly comparable to YPrime's IRT product and competes for similar oncology and rare disease trial mandates.
  • Medidata Solutions (Dassault Systèmes): Industry-leading eClinical platform offering Rave EDC, Rave eCOA, and RTSM/IRT — directly competes with YPrime's eCOA and IRT products for global pharmaceutical sponsor business at much larger scale.
  • Bio-Optronics: Clinical trial workflow technology provider with eCOA, CTMS, and scheduling solutions; competes with YPrime particularly in mid-sized sponsor and academic trial segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

YPrime social profiles

Digital presence

YPrime financial estimates

Financial estimate

Revenue estimate

Valuation estimate

YPrime leadership team

Management profile

Number of profiles

Profiles7 records

YPrime subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

YPrime funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

YPrime M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about YPrime

What does YPrime do?

YPrime provides a unified eClinical technology platform for global clinical trials, delivering enterprise-grade eCOA (Electronic Clinical Outcome Assessment), IRT (Interactive Response Technology), and eConsent solutions, complemented by participant engagement tools and clinical trial consulting services. The platform is designed to accelerate study startup, support complex protocols, and provide inspection-ready data across 100+ countries.

Is YPrime a public or private company?

YPrime is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was YPrime founded?

YPrime was founded in 2008. It employs 251 to 500 people.

Where is YPrime based?

YPrime is headquartered in Malvern, United States, in the North America region.

How does YPrime make money?

Three revenue lines are on record. eClinical Technology Platform (eCOA, IRT, eConsent) is the primary driver. The others are consulting Services and 24/7/365 Global Support.

Who are YPrime's main competitors?

Emerging players on record are Castor and ClinOne. Broad incumbents are IQVIA, Veeva Systems and Oracle Health Sciences (Clinical One / InForm). Direct peers are Signant Health, Clario, Suvoda, Medidata Solutions (Dassault Systèmes) and Bio-Optronics.

Does YPrime have an API?

No public API is recorded for YPrime.

What industry is YPrime in?

YPrime's product category is eClinical Technology / Clinical Trial Software. Its primary akta.pro industry code is HLACAOAC, Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS), with a secondary code of HLACAOAL, Decentralized/Hybrid Trial Enablement (DCT) Platforms. Its NAICS code is 541512 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireYPrime Named to Everest Group's Top 50™ Pharmaceutical Technology Providers, Reinforcing Clinical Trial Technology LeadershipYPrime has been named to Everest Group's Top 50 Pharmaceutical Technology Providers list for 2026, recognizing its leadership in clinical trial technology and market impact. The company supports studies in over 100 countries with solutions available in more than 250 languages, leveraging AI to reduce migration errors and accelerate study builds. This recognition reinforces YPrime's position among pharmaceutical sponsors and CROs seeking integrated, compliant digital execution platforms.FinancialContent Business PageYPrime Named to Everest Group's Top 50™ Pharmaceutical Technology Providers, Reinforcing Clinical Trial Technology LeadershipYPrime has been named to Everest Group's Top 50 Pharmaceutical Technology Providers list for 2026, recognizing its leadership in clinical trial technology solutions including eCOA, IRT, and eConsent. The company was highlighted for its AI-supported eCOA localization, which reduced migration errors by 74% in a 15-study analysis, and its ability to deliver eCOA solutions in timeframes as short as one week for simple studies. YPrime supports clinical studies across more than 100 countries with solutions available in over 250 languages.MyChesCoYPrime Launches AI Calculation Engine for Clinical Trial PlatformYPrime, a clinical trial technology company based in Malvern, PA, launched an AI-powered calculation engine within its eCOA platform that automates how clinical trial data calculations are configured and executed using natural language input.GlobeNewswireYPrime Introduces AI-Powered eCOA Calculation EngineYPrime launched an AI-powered Calculation Engine for its eCOA platform, enabling study teams to define calculation logic conversationally in natural language. The engine generates standardized, traceable calculation models and executes them automatically during the trial, reducing build time and improving consistency. The capability is now available as part of the YPrime eCOA platform.MyChesCoYPrime Launches eCOA Participant Hub to Improve Trial EngagementYPrime recently launched a Participant Hub within its electronic clinical outcome assessment (eCOA) platform, introducing a 'For You' page that centralizes study information, visit schedules, and task tracking to help clinical trial participants better understand study requirements. The company reports that clinical trials face average dropout rates of about 30%, with unclear expectations contributing to reduced adherence and missing data, and internal research showed 46% of participants said clearer explanations would help maintain engagement. The platform is designed to provide structured guidance and reduce participant uncertainty to strengthen adherence and retention.GlobeNewswireYPrime Expands eCOA Platform with Participant HubYPrime launched the eCOA Participant Hub with a 'For You' page to centralize study guidance and task visibility. The hub aims to reduce participant dropout, which averages about 30%, by providing clear study expectations. YPrime will showcase the hub at industry events and offer a virtual preview in April.GlobeNewswireYPrime Wins Two Clinical Trials Arena Excellence Awards for Innovation in AI and Sustainable eCOA PracticesYPrime received two awards for innovation in AI and sustainability at the 2025 Clinical Trials Arena Excellence Awards. The company was recognized for applying AI to accelerate eCOA localization and embedding sustainability into clinical trial workflows.Clinical Trials ArenaClinical Trials Arena Excellence Awards 2025: YPrimeYPrime, a clinical technology provider, received two awards at the 2025 Clinical Trials Arena Excellence Awards: the Innovation award for AI in Clinical Trials and the Environmental award for Sustainable Trials. The company's AI innovation targets migration of paper Clinical Outcome Assessment translations into eCOA software, achieving a 74% reduction in migration errors and 60% fewer rework reports across 15 comparative projects, while its digital-first platforms enabled an 87% reduction in printed trial documents over three years. YPrime also earned an EcoVadis bronze medal and CDP "B" rating in 2024, reflecting maturing environmental management practices.GlobeNewswireYPrime Research Shows 74% Fewer Localization Errors in eCOA Migration with AI-Enabled WorkflowsYPrime released research showing AI-enabled workflows reduce eCOA localization migration errors by 74%, cut screen reports with errors by 60%, and shorten review cycles by 67%. The study, presented at ISPOR 2025, used 15 studies across 11 languages and found zero new error types.GlobeNewswireYPrime Research Shows 74% Fewer Localization Errors in eCOA Migration with AI-Enabled WorkflowsYPrime, a clinical trial technology company, released research at ISPOR 2025 showing that AI-enabled workflows in eCOA (electronic Clinical Outcome Assessment) localization reduced migration errors by 74% compared to human-led processes. The study, which compared 15 studies across 11 languages, also found that AI workflows cut localization review cycles by 67% and reduced screen reports containing errors by 60% while introducing no new error types. YPrime stated this research supports broader language coverage in global trials, enabling faster approvals and earlier study build releases.